| Impact of BRCA1/2 mutation on young women’s 5-year parenthood rates: a prospective comparative study (GENEPSO-PS cohort) |
|
|
|
|
|
|
|
|
|
| The roles of AXIN2 in tumorigenesis and epigenetic regulation |
|
|
|
|
|
|
|
|
|
| Comparison of proctocolectomy and ileal pouch-anal anastomosis to colectomy and ileorectal anastomosis in familial adenomatous polyposis |
|
|
|
|
|
|
|
|
|
| Parental age and Neurofibromatosis Type 1: a report from the NF1 Patient Registry Initiative |
|
|
|
|
|
|
|
|
|
| Desmoid tumors: clinical features and outcome of an unpredictable and challenging manifestation of familial adenomatous polyposis |
|
|
|
|
|
|
|
|
|
| Gastric cancer in three relatives of a patient with a biallelic IL12RB1 mutation |
|
|
|
|
|
|
|
|
|
| 18th annual meeting: Collaborative Group of the Americas on Inherited Colorectal Cancer (CGA-ICC) |
|
|
|
|
|
|
|
|
|
| First-Line sunitinib in patients with renal cell carcinoma (RCC) in von Hippel–Lindau (VHL) disease: clinical outcome and patterns of radiological response |
|
|
|
|
|
|
|
|
|
| Identification of a novel MSH6 germline variant in a family with multiple gastro-intestinal malignancies by next generation sequencing |
|
|
|
|
|
|
|
|
|
| Health professionals’ evaluation of delivering treatment-focused genetic testing to women newly diagnosed with breast cancer |
|
|
|
|
|
|
|
|
|
| Population-based genetic risk prediction and stratification for ovarian cancer: views from women at high risk |
|
|
|
|
|
|
|
|
|
| Estimate of the penetrance of BRCA mutation and the COS software for the assessment of BRCA mutation probability |
|
|
|
|
|
|
|
|
|
| Vestibular schwannoma in a patient with neurofibromatosis type 1: clinical report and literature review |
|
|
|
|
|
|
|
|
|
| Single nucleotide polymorphisms in PDCD6 gene are associated with the development of cervical squamous cell carcinoma |
|
|
|
|
|
|
|
|
|
| The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome |
|
|
|
|
|
|
|
|
|
| Down-regulation of malignant potential by alpha linolenic acid in human and mouse colon cancer cells |
|
|
|
|
|
|
|
|
|
| Desmoid tumour in familial adenomatous polyposis patients: responses to treatments |
|
|
|
|
|
|
|
|
|
| Multiple skin hamartomata: a possible novel clinical presentation of SUFU neoplasia syndrome |
|
|
|
|
|
|
|
|
|
| Long-term outcomes of risk-reducing surgery in unaffected women at increased familial risk of breast and/or ovarian cancer |
|
|
|
|
|
|
|
|
|
| Mitochondrial membrane potential and reactive oxygen species in cancer stem cells |
|
|
|
|
|
|
|
|
|
| Familial and sporadic pancreatic cancer share the same molecular pathogenesis |
|
|
|
|
|
|
|
|
|
| Outcomes of genetic evaluation for hereditary cancer syndromes in unaffected individuals |
|
|
|
|
|
|
|
|
|
| Further evidence for pathogenicity of the TP53 tetramerization domain mutation p.Arg342Pro in Li–Fraumeni syndrome |
|
|
|
|
|
|
|
|
|
| MLH1 promotor hypermethylation does not rule out a diagnosis of Lynch syndrome: a case report |
|
|
|
|
|
|
|
|
|
| A polymorphism at miRNA-122-binding site in the IL-1α 3′UTR is associated with risk of epithelial ovarian cancer |
|
|
|
|
|
|
|
|
|
| Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe |
|
|
|
|
|
|
|
|
|
| Mismatch repair deficient-crypts in non-neoplastic colonic mucosa in Lynch syndrome: insights from an illustrative case |
|
|
|
|
|
|
|
|
|
| Association of reduced XRCC2 expression with lymph node metastasis in breast cancer tissues |
|
|
|
|
|
|
|
|
|
| APC rearrangements in familial adenomatous polyposis: heterogeneity of deletion lengths and breakpoint sequences underlies similar phenotypes |
|
|
|
|
|
|
|
|
|
| Identification of a breast cancer family double heterozygote for RAD51C and BRCA2 gene mutations |
|
|
|
|
|
|
|
|
|
| Detection of inherited mutations for hereditary cancer using target enrichment and next generation sequencing |
|
|
|
|
|
|
|
|
|
| Gly322Asp and Asn127Ser single nucleotide polymorphisms (SNPs) of hMSH2 mismatch repair gene and the risk of triple-negative breast cancer in Polish women |
|
|
|
|
|
|
|
|
|
| Cancer genetic testing panels for inherited cancer susceptibility: the clinical experience of a large adult genetics practice |
|
|
|
|
|
|
|
|
|
| High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registry |
|
|
|
|
|
|
|
|
|
| The secondary bile acid, deoxycholate accelerates intestinal adenoma–adenocarcinoma sequence in Apc min/+ mice through enhancing Wnt signaling |
|
|
|
|
|
|
|
|
|
| Molecular heterogeneity of familial myeloproliferative neoplasms revealed by analysis of the commonly acquired JAK2, CALR and MPL mutations |
|
|
|
|
|
|
|
|
|
| A primary care audit of familial risk in patients with a personal history of breast cancer |
|
|
|
|
|
|
|
|
|
| High-resolution melting (HRM) assay for the detection of recurrent BRCA1/BRCA2 germline mutations in Tunisian breast/ovarian cancer families |
|
|
|
|
|
|
|
|
|
| Phenotype of SDHB mutation carriers in the Netherlands |
|
|
|
|
|
|
|
|
|
| Germline CDKN2A mutations in Brazilian patients of hereditary cutaneous melanoma |
|
|
|
|
|
|
|
|
|
| Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment |
|
|
|
|
|
|
|
|
|
| “It’s all very well reading the letters in the genome, but it’s a long way to being able to write”: Men’s interpretations of undergoing genetic profiling to determine future risk of prostate cancer |
|
|
|
|
|
|
|
|
|
| Muir–Torre syndrome or phenocopy? The value of the immunohistochemical expression of mismatch repair proteins in sebaceous tumors of immunocompromised patients |
|
|
|
|
|
|
|
|
|
| Cribriform-morular variant of papillary thyroid carcinoma: an indication to screen for occult FAP |
|
|
|
|
|
|
|
|
|
| Erratum to: Frequency of 5382insC mutation of BRCA1 gene among breast cancer patients: an experience from Eastern India |
|
|
|
|
|
|
|
|
|
| Association of interleukin-23 receptor gene polymorphisms with risk of bladder cancer in Chinese |
|
|
|
|
|
|
|
|
|
| Genetic 135G/C polymorphism of RAD51 gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls |
|
|
|
|
|
|
|
|
|
| Rapid and cost effective screening of breast and ovarian cancer genes using novel sequence capture method in clinical samples |
|
|
|
|
|
|
|
|
|
| A survey of the practice patterns of gynecologic oncologists dealing with hereditary cancer patients in Japan |
|
|
|
|
|
|
|
|
|
| Distinct gene expression profiles in ovarian cancer linked to Lynch syndrome |
|
|
|
|
|
|
|
|
|
| Genetics of endometrial cancer |
|
|
|
|
|
|
|
|
|
| How harmful is genetic testing for familial adenomatous polyposis (FAP) in young children; the parents’ experience |
|
|
|
|
|
|
|
|
|
| Nucleotide variants of the cancer predisposing gene CDH1 and the risk of non-syndromic cleft lip with or without cleft palate |
|
|
|
|
|
|
|
|
|
| “Would you test your children without their consent?” and other sticky dilemmas in the field of cancer genetic testing |
|
|
|
|
|
|
|
|
|
| A founder MLH1 mutation in Lynch syndrome families from Piedmont, Italy, is associated with an increased risk of pancreatic tumours and diverse immunohistochemical patterns |
|
|
|
|
|
|
|
|
|
| Exploring the association of succinate dehydrogenase complex mutations with lymphoid malignancies |
|
|
|
|
|
|
|
|
|
| Evaluating the utilization of educational materials in communicating about Lynch syndrome to at-risk relatives |
|
|
|
|
|
|
|
|
|
| BRCA1 founder mutations compared to ovarian cancer in Belarus |
|
|
|
|
|
|
|
|
|
| An unusual case of familial adenomatous polyposis with very early symptom occurrence |
|
|
|
|
|
|
|
|
|
| BRCA1 point mutations in premenopausal breast cancer patients from Central Sudan |
|
|
|
|
|
|
|
|
|
| Influence of family history on psychosocial distress and perceived need for treatment in prostate cancer survivors |
|
|
|
|
|
|
|
|
|
| Fertility and apparent genetic anticipation in Lynch syndrome |
|
|
|
|
|
|
|
|
|
| Two Chinese pedigrees for adenomatous polyposis coli: new mutations at codon 1309 and predisposition to phenotypic variations |
|
|
|
|
|
|
|
|
|
| Intronic splicing mutations in PTCH1 cause Gorlin syndrome |
|
|
|
|
|
|
|
|
|
| Analysis of patient reports on the referral process to two NSW cancer genetic services |
|
|
|
|
|
|
|
|
|
| Limited diagnostic value of microsatellite instability associated pathology features in colorectal cancer |
|
|
|
|
|
|
|
|
|
| Novel BRCA1 deleterious mutation (c.1918C>T) in familial breast and ovarian cancer syndrome who share a common ancestry |
|
|
|
|
|
|
|
|
|
| A family history questionnaire improves detection of women at risk for hereditary gynecologic cancer: a pilot study |
|
|
|
|
|
|
|
|
|
| Attitudes and compliance of clinical management after genetic testing for hereditary breast and ovarian cancer among high-risk Southern Chinese females with breast cancer history |
|
|
|
|
|
|
|
|
|
| Mosaic partial deletion of the PTEN gene in a patient with Cowden syndrome |
|
|
|
|
|
|
|
|
|
| Duplex value of caveolin-1 in non-small cell lung cancer: a meta analysis |
|
|
|
|
|
|
|
|
|
| Large genomic rearrangement of BRCA1 and BRCA2 genes in familial breast cancer patients in Korea |
|
|
|
|
|
|
|
|
|
| Potential genetic anticipation in hereditary leiomyomatosis-renal cell cancer (HLRCC) |
|
|
|
|
|
|
|
|
|
| Providing patient education: impact on quantity and quality of family health history collection |
|
|
|
|
|
|
|
|
|
| Deletion of exons 1–3 of the MEN1 gene in a large Italian family causes the loss of menin expression |
|
|
|
|
|
|
|
|
|
| Capsule endoscopy versus magnetic resonance enterography for the detection of small bowel polyps in Peutz–Jeghers syndrome |
|
|
|
|
|
|
|
|
|
| The MUTYH hotspot mutations p.G396D and p.Y179C do not cause substantial genetic susceptibility to biliary cancer |
|
|
|
|
|
|
|
|
|
| Prophylactic total gastrectomy in hereditary diffuse gastric cancer: identification of two novel CDH1 gene mutations—a clinical observational study |
|
|
|
|
|
|
|
|
|
| Baseline and post prophylactic tubal–ovarian surgery CA125 levels in BRCA1 and BRCA2 mutation carriers |
|
|
|
|
|
|
|
|
|